All Stories

  1. Differences in cNOS/iNOS Activity during Resistance to Trypanosoma cruzi Infection in 5-Lipoxygenase Knockout Mice

    Article • Mediators of Inflammation, October 2019, Hindawi Publishing Corporation

    Dr CAROLINA PANIS, Phileno Pinge-Filho

  2. Selective Antiprotozoal Activity of Nitric Oxide-releasing Chitosan Nanoparticles Against Trypanosoma cruzi: Toxicity and Mechanisms of Action

    Article • Current Pharmaceutical Design, May 2018, Bentham Science Publishers

    Dr Amedea B. Seabra, Phileno Pinge-Filho

  3. Treatment with low doses of aspirin during chronic phase of experimental Chagas’ disease increases oesophageal nitrergic neuronal subpopulation in mice

    Article • International Journal of Experimental Pathology, December 2017, Wiley

    debora santana, Phileno Pinge-Filho

  4. Myenteric neuroprotective role of aspirin in acute and chronic experimental infections with Trypanosoma cruzi

    Article • Neurogastroenterology & Motility, May 2017, Wiley

    debora santana, Bruno Fernando Cruz Lucchetti, Phileno Pinge-Filho

  5. Inhibition of Cyclooxygenase-1 and Cyclooxygenase-2 Impairs Trypanosoma cruzi Entry into Cardiac Cells and Promotes Differential Modulation of the Inflammatory Response

    Article • Antimicrobial Agents and Chemotherapy, August 2014, ASM Journals

    Phileno Pinge-Filho